01 / COMPOSITION
Active Ingredient & Assay
Each tablet contains Phenobarbitone IP 30 mg formulated with pharmaceutical-grade excipients, adhering to stringent Pharmacopoeial limits for assay, dissolution, and content uniformity.
Blessme · Neuro Products
Phenobarbitone 30 mg – BARZOX-30
BARZOX-30 is a Phenobarbitone Tablet IP 30 mg formulation by Blessme, the neurology division of Dellwich Lifescience LLP. Manufactured under applicable quality standards, it offers verified product specifications for professional pharmaceutical requirements. Available for eligible PCD franchise, third-party manufacturing, and hospital supply enquiries.
WHO-GMP Certified
Schedule H Prescription
Pan-India Dispatch
Pharmacopoeial PurityIP standard active ingredient assay
WHO-GMP CertifiedManufactured in accredited units
Moisture-Resistant Blister10x10 Alu-PVC strip packaging
Pan-India B2B SupplyPrompt dispatch from Ahmedabad
Product SpecificationsAbout Phenobarbitone 30 mg
About Phenobarbitone 30 mg
(BARZOX-30)
Detailed technical data, active pharmaceutical ingredient specifications, dosage format, and regulatory classification for BARZOX-30.
Blessme · Neuro Products
Phenobarbitone 30 mg – BARZOX-30
Phenobarbitone Tablets IP 30 mg is an anticonvulsant medicine used in the management of certain seizure disorders under medical supervision.
Management of Generalized Tonic-Clonic Seizures Management of Partial-Onset Seizures Control of Certain Epileptic Seizure Disorders Use Under Qualified Medical Supervision
- Product Brand Name
- BARZOX-30
- Active Pharmaceutical Ingredient
- Phenobarbitone IP (30 mg)Verified
- Therapeutic Class
- Anticonvulsant / Barbiturate / Antiepileptic
- Dosage Form
- Oral Solid Tablet (Uncoated / Film-Coated)
- Strength
- 30 mg per tablet
- Standard Packaging
- 10 x 10 Blister Pack (100 Tablets Box)
- Regulatory Category
- Schedule H Prescription Drug (Rx Only)
- Marketing Division
- Blessme · Neuro & Psychiatric Products
- Marketing & Distribution Company
- Dellwich Lifescience LLP, Ahmedabad, Gujarat
- Storage Condition
- Store protected from light and moisture at below 30°C
- Quality Standard
- Manufactured in WHO-GMP & ISO 9001:2015 Certified Units
- Country of Origin
- India
Quality & Production
Quality assurance and compliance
BARZOX-30 is manufactured under controlled pharmaceutical production processes, focusing on batch-to-batch consistency, quality assurance, and compliance with applicable manufacturing standards.
02 / PACKAGING
High-Barrier Blister Pack
Packaged in tamper-evident Alu-PVC blister strips that safeguard against ambient moisture, temperature variations, and photodegradation during transportation and storage.
03 / DOCUMENTATION
COA & Batch Records
Complete technical dossier, Certificate of Analysis (COA), Material Safety Data Sheet (MSDS), and stability data are readily furnished for hospital procurement and institutional audits.
04 / COMPLIANCE
WHO-GMP & Schedule M
Manufactured in accredited WHO-GMP and Schedule M certified facilities following Good Laboratory Practices (GLP) and validated automated compression and blister packaging.
Clinical Profile & Precautions
Approved Indications & Safety Guidelines
As a Schedule H barbiturate-class medication, Phenobarbitone requires responsible administration and strict adherence to registered medical prescription guidelines.
Prescription-Only Schedule H Medication Notice
Phenobarbitone is a potent central nervous system depressant and anticonvulsant. It carries potential risks of sedation, tolerance, dependence, and significant drug-drug interactions. It must strictly be administered under the direction of a licensed neurologist or physician. Do not abruptly cease therapy without medical guidance to avoid rebound seizures.
Clinical Indications
Phenobarbitone 30 mg (BARZOX-30) is indicated in evidence-based neurological practice for:
- Generalized Tonic-Clonic Seizures: Long-term prophylaxis and control of grand mal epilepsy.
- Partial / Focal Seizures: Effective as monotherapy or adjunctive therapy in complex partial seizures.
- Status Epilepticus Maintenance: Post-acute stabilization following acute emergency anticonvulsant protocols.
- Neonatal Seizure Protocols: Under specialized pediatric neurology supervision.
Pharmacology & Precautions
Pharmacological parameters and essential monitoring protocols for healthcare practitioners:
- Mechanism of Action: Allosteric modulation of GABAA receptors, prolonging chloride ionophore open time and raising the seizure threshold.
- Contraindications: Severe respiratory depression, acute intermittent porphyria, and known barbiturate hypersensitivity.
- Hepatic / Renal Care: Regular monitoring of liver and kidney function advised during prolonged therapy.
- Drug Interactions: Induces cytochrome P450 hepatic enzymes, which may reduce the efficacy of oral contraceptives, warfarin, and other co-administered agents.
Manufacturing & Marketing
Dellwich Lifescience LLPBlessme · Neuro & Psychiatric Division
About Dellwich Lifescience
Trusted Neuro Pharmaceutical Manufacturer in Ahmedabad, Gujarat
Dellwich Lifescience LLP is a pharmaceutical company based in Ahmedabad, Gujarat, focused on pharmaceutical manufacturing, quality assurance, and product distribution. Through our specialized neurology division, Blessme, we offer neuro and psychiatry pharmaceutical products, including BARZOX-30 (Phenobarbitone Tablets IP 30 mg).
We support eligible PCD pharma franchise partners, pharmaceutical distributors, and institutional supply enquiries across India, with an emphasis on reliable distribution and consistent product quality.
Commercial PartnershipsBARZOX-30 Supply &
BARZOX-30 Supply &
Pharmaceutical Distribution
Whether you are seeking BARZOX-30 (Phenobarbitone Tablets IP 30 mg) for eligible PCD pharma franchise opportunities, third-party pharmaceutical manufacturing, or institutional hospital supply, Dellwich Lifescience LLP supports professional supply enquiries with a focus on product quality, reliable distribution, and dependable pharmaceutical supply solutions.
Monopoly PCD Franchise
Secure exclusive territory rights for BARZOX-30 and the entire Blessme Neuro range with visual aids, MR bags, LBLs, catch covers, and aggressive margin support.
Third-Party Manufacturing
Contract manufacturing solutions for neurology brands with customizable batch sizes, fast turnaround, stringent QA/QC batch testing, and regulatory documentation.
Hospital & Institutional Supply
Direct bulk procurement partnerships for private hospitals, neurology clinics, psychiatric institutes, and government medical tenders with pan-India cold-chain logistics.
Common Questions
Frequently Asked Questions about BARZOX-30
Verified answers to common clinical, commercial, and regulatory queries regarding Phenobarbitone 30 mg tablets.
What is BARZOX-30 and what is its active ingredient?
BARZOX-30 is a prescription pharmaceutical formulation manufactured under the Blessme division of Dellwich Lifescience LLP. Its active pharmaceutical ingredient is Phenobarbitone IP at a strength of 30 mg per tablet, an established barbiturate-class anticonvulsant and antiepileptic agent.
What are the primary clinical indications of Phenobarbitone 30 mg?
Phenobarbitone 30 mg (BARZOX-30) is indicated primarily for the treatment and prophylaxis of generalized tonic-clonic (grand mal) seizures, partial seizures (focal epilepsy), status epilepticus maintenance, and specific neonatal seizure protocols under neurologist supervision.
How does Phenobarbitone 30 mg work in the central nervous system?
Phenobarbitone acts by allosterically binding to GABAA receptors in the central nervous system. This enhances GABA-mediated chloride influx, hyperpolarizes post-synaptic neuronal membranes, raises seizure thresholds, and dampens the propagation of abnormal epileptogenic discharges.
Can BARZOX-30 be purchased over-the-counter without a doctor's prescription?
No. BARZOX-30 contains Phenobarbitone, which is classified as a Schedule H / prescription barbiturate drug in India. It must be dispensed exclusively against a valid prescription from a registered medical practitioner.
What packaging and strip configurations are available for BARZOX-30?
BARZOX-30 is packaged in high-barrier 10 x 10 tablet blister packs designed to protect the formulation from ambient moisture and light. Custom packaging configurations are available for hospital supply and bulk distribution.
Who manufactures and markets BARZOX-30 in Ahmedabad, India?
BARZOX-30 is marketed and distributed by Dellwich Lifescience LLP, headquartered in Science City, Ahmedabad, Gujarat, under its dedicated neurology and psychiatry portfolio 'Blessme Neuro Products'.
Is PCD pharma franchise available for BARZOX-30 and Blessme Neuro products?
Yes. Dellwich Lifescience LLP provides exclusive monopoly-based PCD pharma franchise opportunities for the entire Blessme Neuro and Psychiatric range, including BARZOX-30, backed by comprehensive marketing materials and promotional support.
How can hospitals and distributors place bulk orders for BARZOX-30?
Hospitals, government procurement bodies, wholesalers, and licensed pharma distributors can contact Dellwich Lifescience LLP by calling +91-9909931992 or emailing [email protected] to obtain commercial quotes, Certificates of Analysis (COA), and dispatch schedules.
Direct Pharmaceutical Enquiry
Need Verified Information or Bulk Supply of BARZOX-30?
Connect directly with Dellwich Lifescience LLP for commercial quotes, monopoly PCD distributorship availability, Certificates of Analysis (COA), or third-party manufacturing specifications.
Direct Manufacturer Pricing & Transparent MOQ
Exclusive PCD Monopoly Rights for Designated Districts
Fast Dispatch from Ahmedabad with GST Invoicing
Comprehensive Marketing, Visual Aids & Promotional Inputs
Quick Assistance & Orders
Enquire About BARZOX-30
Get bulk pricing, PCD monopoly availability, and technical documentation for Phenobarbitone 30 mg.